Norbert Brock
Impact in
- Toxicology top 0.2%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Papers in
- Toxicology 33
- Bioactive Compounds and Antitumor Agents 32
- Pharmacology 18
- Pharmacogenetics and Drug Metabolism 12
- Co-authors
- H. J. Hohorst (8 shared papers)Jurij Stekar (8 shared papers)Jörg Pohl (7 shared papers)Herbert Arnold (2 shared papers)J. Pohl (8 shared papers)W Scheef (5 shared papers)H. O. Klein (3 shared papers)Ulf Niemeyer (2 shared papers)
In The Last Decade
Norbert Brock
77 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 94
- Toxicology 423
- Pharmacology 355
- Pathology and Forensic Medicine 570
- Cancer Research 221
- Urology 84
Countries citing papers authored by Norbert Brock
This map shows the geographic impact of Norbert Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Brock more than expected).
Fields of papers citing papers by Norbert Brock
This network shows the impact of papers produced by Norbert Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Brock. The network helps show where Norbert Brock may publish in the future.
Co-authors
The 25 scholars most cited alongside Norbert Brock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide. | 1979 | 165 |
| 2 | 1958 | 136 | |
| 3 | 1967 | 134 | |
| 4 | 1971 | 125 | |
| 5 | 1982 | 117 | |
| 6 | Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results. | 1979 | 104 |
| 7 | 1981 | 103 | |
| 8 | 1977 | 101 | |
| 9 | 1958 | 100 | |
| 10 | 1981 | 99 | |
| 11 | Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture. | 1989 | 99 |
| 12 | [ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO]. | 1963 | 78 |
| 13 | Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat. | 1983 | 75 |
| 14 | 1983 | 69 | |
| 15 | 1983 | 68 | |
| 16 | Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds. | 1976 | 66 |
| 17 | Pharmacological and toxicological properties of azelastine, a novel antiallergic agent. | 1981 | 66 |
| 18 | 1958 | 63 | |
| 19 | 1981 | 53 | |
| 20 | 1962 | 42 |
About Norbert Brock
Norbert Brock is a scholar working on Toxicology, Pharmacology, Pathology and Forensic Medicine, Molecular Biology and Organic Chemistry, having authored 83 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (33 papers), Bioactive Compounds and Antitumor Agents (32 papers), Chemotherapy-induced organ toxicity mitigation (17 papers), Pharmacogenetics and Drug Metabolism (12 papers), Synthesis and biological activity (7 papers), Organophosphorus compounds synthesis (7 papers), Analytical Methods in Pharmaceuticals (6 papers) and Statistical Methods in Clinical Trials (5 papers). The work is most often cited by research in Toxicology (423 citations), Pharmacology (355 citations), Pathology and Forensic Medicine (570 citations), Cancer Research (221 citations) and Urology (84 citations). Norbert Brock has collaborated with scholars based in Germany, China and Sweden. Frequent co-authors include H. J. Hohorst, Jurij Stekar, Jörg Pohl, Herbert Arnold, J. Pohl, W Scheef, H. O. Klein, Ulf Niemeyer, B Schneider and Robert Gross. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Die Naturwissenschaften, Naunyn-Schmiedeberg s Archives of Pharmacology, Cancer and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.